Pearce Samantha — SEC Form 4 filings
SEC reporting owner CIK 1805688. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-19 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 6,907 shares, $1,625,977 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 6,907 shares @ $235.41 ($1,625,977) in Jazz Pharmaceuticals plc, filed 2026-06-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | 14 | — | 1 leg · 6,907 sh · $1,625,977 | 19 |
Form 4 filings — Pearce Samantha
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 780 @ $261.62 | EDGAR |
| 2026-07-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 2,527 @ $237.72 | EDGAR |
| 2026-06-01 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 6,907 @ $109.45 · Sale (S): 6,907 @ $235.41 · Option exercise (M): 6,907 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 2,503 @ $188.69 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 9,782 @ $0 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,637 @ $0 · Tax withholding (F): 1,599 @ $171.16 | EDGAR |
| 2025-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 577 @ $116.10 | EDGAR |
| 2025-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 1,905 @ $138.95 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 11,941 @ $0 · Grant/award (A): 5,778 @ $0 | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,533 @ $0 · Tax withholding (F): 1,365 @ $122.62 | EDGAR |
| 2024-08-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 6,996 @ $0 | EDGAR |
| 2024-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 2,474 @ $117.53 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 5,065 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,210 @ $0 · Tax withholding (F): 1,038 @ $119.13 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1805688 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →